Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 1301
Selected: 0
NCT IDTitle
NCT02318082Study of Individual Adult and Pediatric Patient Dose-escalated Interleukin-2 Therapy for Refractory Chronic GVHD
NCT03534323Duvelisib and Venetoclax in Relapsed or Refractory CLL or SLL or RS
NCT01663090Ferumoxytol-Enhanced MRI in Adult/Pedi Sarcomas
NCT06502483PRISM for Depression and Anxiety in Young Adults With Cancer
NCT00165230Thalidomide in Combination With Temodar in Patients With Neuroendocrine Tumors
NCT02912572Avelumab in Patients With MSS, MSI-H and POLE-mutated Recurrent or Persistent Endometrial Cancer and of Avelumab/Talazoparib and Avelumab/Axitinib in Patients With MSS Recurrent or Persistent Endometrial Cancer
NCT05600101Development and Piloting an Avatar-based Intervention to Support Patients Undergoing Stem Cell Transplantation
NCT03429803DAY101 In Gliomas and Other Tumors
NCT03576872The GI Binder: A Psychoeducational Intervention for Gastrointestinal Cancer Patients
NCT00782275Avastin and Temsirolimus Following Tyrosine Kinase Inhibitor Failure in Patients With Advanced Renal Cell Carcinoma
NCT00165412Breast MRI Screening in Women Treated With Mediastinal Irradiation for Hodgkin's Disease
NCT00788775Nilotinib in TKI Resistant or Intolerant Patients With Metastatic Mucosal, Acral, or Chronically Sun Damaged Melanoma
NCT00545792Safety Study Of Avastin And Pelvic Radiation In Women With Recurrent Gynecological Cancers
NCT00936611LBH589 in Relapsed or Relapsed and Refractory Waldenstrom's Macroglobulinemia
NCT00574899Prostate Biomarker Study
NCT02752009Evaluation Of Lymph Nodes After Neoadjuvant Chemotherapy
NCT01465334Ofatumumab With High Dose Methylprednisone Followed by Ofatumumab and Alemtuzumab in 17p CLL
NCT01066663Pyrimethamine for the Treatment of Relapsed Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
NCT00809367Collection and Banking of Leukemia Cells MDS/AML
NCT01664000A Safety, Pharmacokinetic and Pharmacodynamic Study of Kevetrin in Patients With Advanced Solid Tumors
NCT01534078Brentuximab Vedotin Plus AVD in Limited-stage Hodgkin Lymphoma
NCT06056323A Study of HB0045 Injection in Patients With Advanced Solid Tumors
NCT04007588A Phase II Trial of Neoadjuvant Treatment With PD-1 Inhibition (Nivolumab) With or Without IDO Inhibition (BMS-986205) and With or Without CTLA-4 Inhibition (Ipilimumab) in Resectable Stage III or IV Melanoma
NCT06623097Exercise and Nutrition for Older Cancer Survivors and Their Support Person: The Vitality Study
NCT01740219Promoting Organizational Capacity to Implement Cancer Control Programs Among Latino Churches
NCT01239394Ofatumumab for Initial Systemic Treatment of Indolent B-cell Lymphoma
NCT04356729A Phase II Trial of PD-L1 Therapy Combined With Anti-VEGF Therapy in Unresectable or Metastatic Melanoma
NCT01148056Intensity Modulated Radiation Therapy (IMRT) for Patients With Rectal Cancer
NCT03125239Combination Merestinib and LY2874455 for Patients With Relapsed or Refractory Acute Myeloid Leukemia
NCT00842257Panitumumab in Cetuximab Refractory KRAS Wild-Type Colorectal Cancer
NCT00134654Two Doses of Conjugated Estrogen (Premarin) in Patients With Androgen-Independent Prostate Cancer
NCT00090857Letrozole in Preventing Breast Cancer in Postmenopausal Women
NCT01339039Plerixafor (AMD3100) and Bevacizumab for Recurrent High-Grade Glioma
NCT00230542Carboplatin and Pemetrexed in Recurrent Platinum Sensitive Ovarian Cancer
NCT01164956Methylphenidate for Cancer-Related Fatigue
NCT02040857Palbociclib in Combination With Adjuvant Endocrine Therapy for Hormone Receptor Positive, HER2 Negative Invasive Breast Cancer
NCT00299767Phase I Study of Sequential Cord Blood Transplants
NCT01670500Cisplatin vs. Doxorubicin/Cyclophosphamide in BrCa
NCT00385853PTK787/ZK 222584 in Combination With Temozolomide and Radiation in Patients With Glioblastoma Taking Enzyme-Inducing Anti-Epileptic Drugs
NCT04197310Cabozantinib and Nivolumab for Carcinoid Tumors
NCT06317220Vedolizumab for the Treatment of Collagenous Gastritis
NCT05922761BElumosudil for Bronchiolitis Obliterans Prevention/Therapy (BEBOP)
NCT01154920Paclitaxel, Carboplatin and Cetuximab (PCC) With Cetuximab, Docetaxel, Cisplatin and Fluorouracil (C-TPF) in Previously Untreated Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma
NCT05774886Implantable Microdevice for TNBC - Pilot Study
NCT07465276Neoadjuvant Ficerafusp Alfa With Pembrolizumab in Resectable SCC
NCT00827359Biomarker Trial of Everolimus in Patients With Advanced Renal Cell Carcinoma
NCT04339062Cemiplimab in AlloSCT/SOT Recipients With CSCC
NCT00148668Preoperative Herceptin/Navelbine Versus Taxotere/Carboplatin/Herceptin in HER-2 Positive Breast Cancer
NCT00215462Vinorelbine in Unresectable or Metastatic Esophageal and Gastric Adenocarcinoma
NCT03716180DAPHNe: Paclitaxel/Trastuzumab/Pertuzumab in HER2-Positive BC